How to Get Tadalafil (Generic) in New Hampshire

Generic tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor available in 2.5 mg, 5 mg, 10 mg, and 20 mg tablet strengths following FDA approval of generic formulations in 2018. The branded version is sold as Cialis. Generic tadalafil carries FDA approval for treating erectile dysfunction through either as-needed or daily dosing regimens, and for managing benign prostatic hyperplasia (BPH) symptoms at a 5 mg daily dose. As a prescription-only, non-scheduled medication, generic tadalafil operates under different regulatory guidelines than controlled substances regarding prescribing authority and pharmacy transfer procedures.

The direct answer: New Hampshire residents can get generic tadalafil through a telehealth visit, an in-person visit with an MD, DO, APRN, or PA, or a 503A compounding pharmacy that ships statewide, because New Hampshire allows synchronous telehealth prescribing of non-controlled medications without a prior in-person visit. What is not stable is the price you will pay and whether your specific insurance plan covers it: commercial coverage, New Hampshire Medicaid managed-care rules, and cash prices at any given pharmacy change over time and were not independently verified against a primary NH regulatory or payer source for this article, so they need to be confirmed directly before you rely on them.

The useful question for most readers is not "is tadalafil available in New Hampshire", it clearly is, through multiple channels, but which channel is fastest and cheapest for your specific insurance status and dose, and that answer depends on facts (your plan's formulary, a specific pharmacy's cash price, current Medicaid managed-care policy) that this article cannot verify on your behalf.

What is established about prescribing tadalafil by telehealth in New Hampshire

Telehealth prescribing of non-controlled medications, which includes tadalafil, is broadly permitted across most states, including New Hampshire, without requiring a prior in-person exam, as long as the encounter is a real synchronous clinical evaluation. A prescriber conducting a telehealth visit for ED or BPH would be expected to document medical history, current medications, cardiovascular risk factors, and any contraindications to PDE5 inhibitors before prescribing.

The specific statutory citations, the exact scope of the New Hampshire Board of Medicine's current telemedicine rule, and whether NH has adopted any additional documentation requirements beyond the general clinical standard were not verified against a primary New Hampshire regulatory source for this draft. Before publishing a claim that names a specific RSA section or rule number, that citation needs to be checked directly against the New Hampshire Office of Professional Licensure and Certification or Board of Medicine website, since board rules are amended periodically.

Who can prescribe tadalafil

MDs and DOs can prescribe tadalafil in any state, including New Hampshire. Nurse practitioners (APRNs) and physician assistants (PAs) can also prescribe it where state scope-of-practice law allows, and many states, New Hampshire likely among them, grant APRNs full or nearly full prescriptive authority for non-controlled drugs. The exact current scope of NH APRN and PA prescriptive authority, including any collaborative-agreement requirements for PAs, should be confirmed against the New Hampshire Board of Nursing and Board of Medicine rather than assumed from a general description, since scope-of-practice law is state-specific and subject to change.

In practice, most straightforward ED prescriptions in the United States are written in primary care rather than by urology or cardiology specialists, though the exact proportion nationally, and whether that pattern holds specifically in New Hampshire, was not verified against a checkable source for this article and should be treated as a general clinical impression rather than a cited statistic.

Labs before starting tadalafil

Before starting a PDE5 inhibitor, many prescribers order baseline labs, particularly for patients over 40 or with cardiovascular risk factors: a fasting lipid panel, fasting glucose or hemoglobin A1c, and testosterone if hypogonadism is suspected as a contributing cause of ED. This is a common clinical practice pattern rather than a New Hampshire-specific legal requirement, and specialty-society guidance on the exact recommended workup should be checked against the current published guideline from the American Urological Association or an equivalent body rather than a secondhand summary.

Cardiovascular risk stratification matters because PDE5 inhibitors interact with nitrates and can affect blood pressure in combination with alpha-blockers (see below). If you have recent labs from another provider, ask the prescribing platform or clinic whether they will accept uploaded results instead of requiring a repeat draw; policies vary by practice.

503A compounding pharmacies

A 503A compounding pharmacy prepares a medication for a specific named patient under a valid prescription, as distinct from a 503B outsourcing facility, which produces larger batches without patient-specific orders. The FDA's compounding policy framework describes the general rules governing 503A pharmacy sourcing and prescription requirements, though the specific policy documents were not independently verified for this draft and should be checked directly with the FDA before citing.

State-licensed 503A pharmacies may compound tadalafil into custom strengths (for example, doses between the commercial 2.5 mg, 5 mg, 10 mg, and 20 mg tablets) or alternate forms such as troches, and many ship across state lines to patients with a valid prescription. Compounded tadalafil is not an FDA-approved product in the way the commercially manufactured tablet is; it relies on the FDA's compounding framework rather than a full New Drug Application review, and its quality depends on the individual pharmacy's sourcing and practices. Whether a specific NH-licensed 503A pharmacy currently ships tadalafil, and its actual turnaround time, needs to be confirmed directly with that pharmacy, since compounding pharmacy operations and licensure status can change.

Insurance and cost: what's likely to be true, and what you must check yourself

Commercial insurance plans generally cover generic tadalafil, often with a quantity limit and sometimes a prior authorization requirement, particularly for higher on-demand doses (10 mg or 20 mg) versus the lower daily 5 mg dose. Medicaid coverage for tadalafil prescribed specifically for erectile dysfunction is inconsistent across states and plans, and many state Medicaid programs exclude ED medications from coverage while sometimes covering the same drug for an FDA-approved indication like BPH.

Whether New Hampshire Medicaid managed-care plans (or any specific commercial NH plan) currently cover tadalafil for ED or BPH, what prior-authorization documentation they require, and what their turnaround time is, are all plan-specific and date-sensitive facts that were not verified against a primary payer source for this draft. Do not treat any cost or coverage figure in this article, or elsewhere, as current without checking your specific plan's formulary or calling the pharmacy.

Generic tadalafil is typically inexpensive relative to brand Cialis, and discount programs can lower cash prices further, but exact per-tablet prices vary by pharmacy, strength, and quantity, and change over time. If cost matters to your decision, compare your plan's copay, a retail cash price with a discount card, and a telehealth subscription's bundled price directly, rather than relying on a published range.

Dosing: daily versus on-demand

The FDA-approved prescribing information for tadalafil describes two distinct ED dosing strategies (FDA label, accessdata.fda.gov):

• Daily dosing: 2.5 mg or 5 mg taken at approximately the same time each day, providing continuous drug exposure without needing to time a dose around sexual activity.
• On-demand dosing: 10 mg or 20 mg taken at least 30 minutes before anticipated sexual activity, with effects that can persist beyond 24 hours due to tadalafil's long half-life relative to other PDE5 inhibitors.

For BPH symptoms, only the 5 mg daily dose carries FDA approval; higher or on-demand dosing is not an approved BPH regimen. A prescriber, not this article, should determine which regimen and dose fits an individual patient's indication, kidney and liver function, and concurrent medications. This article does not provide individualized dosing advice.

Cardiovascular safety and drug interactions

Tadalafil, like other PDE5 inhibitors, is contraindicated with nitrate medications (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) because the combination can cause a severe, potentially dangerous drop in blood pressure. This is a class-level, well-established contraindication reflected in the FDA label linked above, not a New Hampshire-specific rule.

Co-administration with alpha-blockers (commonly prescribed for BPH or hypertension, such as tamsulosin) requires caution because both drug classes lower blood pressure; the FDA label recommends starting at the lowest tadalafil dose and monitoring for symptoms of low blood pressure such as lightheadedness when the two are combined. Patients with unstable cardiovascular disease, recent heart attack or stroke, or certain arrhythmias may not be appropriate candidates for PDE5 inhibitors; that determination requires an individualized clinical evaluation, not a general statement in this article. If you experience chest pain, a sudden drop in blood pressure, sudden vision loss, or an erection lasting more than four hours after taking tadalafil, seek urgent medical care rather than waiting for a routine follow-up.

What is established, what is plausible, and what is not established

Established: Tadalafil is FDA-approved for ED and BPH at defined doses; it is a non-controlled prescription drug; it carries an absolute contraindication with nitrates and a documented interaction with alpha-blockers.

Plausible but not verified for this article: The specific New Hampshire statutory and board-rule citations governing telehealth prescribing, the exact current scope of APRN and PA prescriptive authority in NH, and the general clinical pattern that most ED prescriptions originate in primary care.

Not established from the material available here: Any specific NH Medicaid managed-care coverage rule for tadalafil, any specific commercial NH insurer's prior-authorization turnaround time, and current cash prices at NH retail or compounding pharmacies. These are the facts most likely to be wrong if copied without a direct check, because they change and were not sourced from a primary NH regulatory or payer document.

Verification checklist: stable facts versus facts you must confirm yourself

Use this to separate what you can trust from a general reference source versus what changes and needs a direct, dated check before you act on it.

Stable (federal regulatory and clinical facts, unlikely to change quickly):

• Tadalafil is FDA-approved for ED (on-demand or daily) and for BPH at 5 mg daily.
• Generic tadalafil has been available in the US since 2018.
• Tadalafil is absolutely contraindicated with nitrates.
• Tadalafil is not a scheduled/controlled substance.
• 503A compounding requires a patient-specific prescription; 503B does not.

Confirm with your prescriber (clinical judgment, individualized):

• Whether you need baseline labs before starting, and which ones.
• Whether daily or on-demand dosing fits your situation.
• Whether an alpha-blocker or other medication you take requires a dose adjustment or extra monitoring.
• Whether your cardiovascular history makes tadalafil inappropriate without further workup.

Confirm directly and note the date you checked (changes over time, plan- or pharmacy-specific):

• Whether your specific insurance plan covers generic tadalafil, and under what quantity limit or prior-authorization terms.
• Whether New Hampshire Medicaid or your specific managed-care plan covers tadalafil for ED, BPH, or neither, as of today.
• The current cash price at the specific pharmacy you plan to use, with and without a discount card.
• Whether a specific 503A compounding pharmacy is currently licensed, in stock, and shipping to New Hampshire, and its current turnaround time.
• The current scope-of-practice rule for APRNs and PAs prescribing non-controlled medications in New Hampshire, checked against the state licensing board rather than a secondary summary.

If a fact in this second category cannot be verified at the point of care, treat any number you have read (including in this article) as an estimate, not a commitment, and confirm it by phone or through the payer's or pharmacy's own current documentation.

Frequently asked questions